Repligen (RGEN) Tops Q3 EPS by 7c, Revenues Beat; Raises FY19 EPS/Revenue Guidance Above Consensus
Tweet Send to a Friend
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.26, $0.07 better than the analyst estimate of $0.19. Revenue for the quarter ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
